{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T06:15:15Z","timestamp":1778134515384,"version":"3.51.4"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There is rising detection of unregulated stimulants (e.g. cocaine and methamphetamine) in toxicology results among people who died of unregulated drug poisoning. Nevertheless, little research describes the population-level trends of incident (new) stimulant use disorder (StUD) diagnoses. This study reports on trends of incident StUD diagnoses pre- and post-Covid-19 public health emergency in British Columbia (BC), Canada.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Interrupted time series analyses were conducted with BC\u2019s COVID-19 public health emergency declaration on March 16, 2020 as the interruption point. Descriptive statistics on demographic and health service contact were conducted for the population diagnosed before (January 1, 2013 - March 16, 2020) and after (March 17, 2020 - December 31, 2024) the COVID-19 pandemic emergency declaration. Seasonal autoregressive integrated moving average (sARIMA) models were used to .estimate changes to incident StuD diagnoses rates before and after the COVID-19 pandemic declaration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>38, 217 people were identified with incident StUD diagnoses between January 1, 2013 and March 31, 2024. The average diagnosis rate of incident StUD was 5.18 per 100, 000 in the pre-pandemic period and increased by 19.9% to 6.21 per 100, 000 in the post-pandemic period. The estimated increase in slope (ramp) of incident StUD was 0.0315 cases per 100, 000 population per month (95% CI: -0.00182, 0.06482).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We identified a rate of increase in incident StUD diagnoses since the COVID-19 pandemic declaration in BC that was not statistically significant. Our study highlights the need for more comprehensive linked data -including, administrative health data, surveys, and other services\/program data (e.g., community services, private sector) to better disentangle StUD incidence and prevalence to inform services to meet the needs of people with StUD. Stimulant use, Stimulant use disorder, pandemic, Covid-19, methamphetamines, cocaine, interrupted time series.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2026.1682481","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T05:41:43Z","timestamp":1778132503000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Trends of incident stimulant use disorder diagnoses before and after the COVID-19 pandemic in British Columbia (2013-2024): a population-based study"],"prefix":"10.3389","volume":"17","author":[{"given":"Roshni","family":"Desai","sequence":"first","affiliation":[{"name":"British Columbia (BC) Centre for Disease Control","place":["Vancouver, BC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Hu","sequence":"additional","affiliation":[{"name":"British Columbia (BC) Centre for Disease Control","place":["Vancouver, BC, Canada"]},{"name":"School of Population and Public Health, University of British Columbia","place":["Vancouver, BC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zhao","sequence":"additional","affiliation":[{"name":"British Columbia (BC) Centre for Disease Control","place":["Vancouver, BC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shania","family":"Au","sequence":"additional","affiliation":[{"name":"British Columbia (BC) Centre for Disease Control","place":["Vancouver, BC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Chen","sequence":"additional","affiliation":[{"name":"British Columbia (BC) Centre for Disease Control","place":["Vancouver, BC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mallory","family":"Flynn","sequence":"additional","affiliation":[{"name":"British Columbia (BC) Centre for Disease Control","place":["Vancouver, BC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Irvine","sequence":"additional","affiliation":[{"name":"British Columbia (BC) Centre for Disease Control","place":["Vancouver, BC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hind","family":"Sbihi","sequence":"additional","affiliation":[{"name":"British Columbia (BC) Centre for Disease Control","place":["Vancouver, BC, Canada"]},{"name":"School of Population and Public Health, University of British Columbia","place":["Vancouver, BC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brooke","family":"Kinniburgh","sequence":"additional","affiliation":[{"name":"British Columbia (BC) Centre for Disease Control","place":["Vancouver, BC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kali-Olt","family":"Sedgemore","sequence":"additional","affiliation":[{"name":"British Columbia (BC) Centre for Disease Control","place":["Vancouver, BC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"Marchand","sequence":"additional","affiliation":[{"name":"School of Population and Public Health, University of British Columbia","place":["Vancouver, BC, Canada"]},{"name":"Foundry","place":["Vancouver, BC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Bartlett","sequence":"additional","affiliation":[{"name":"British Columbia (BC) Centre for Disease Control","place":["Vancouver, BC, Canada"]},{"name":"School of Population and Public Health, University of British Columbia","place":["Vancouver, BC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveed","family":"Janjua","sequence":"additional","affiliation":[{"name":"British Columbia (BC) Centre for Disease Control","place":["Vancouver, BC, Canada"]},{"name":"School of Population and Public Health, University of British Columbia","place":["Vancouver, BC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Crabtree","sequence":"additional","affiliation":[{"name":"British Columbia (BC) Centre for Disease Control","place":["Vancouver, BC, Canada"]},{"name":"School of Population and Public Health, University of British Columbia","place":["Vancouver, BC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Palis","sequence":"additional","affiliation":[{"name":"British Columbia (BC) Centre for Disease Control","place":["Vancouver, BC, Canada"]},{"name":"School of Population and Public Health, University of British Columbia","place":["Vancouver, BC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"B1","article-title":"Unregulated Drug Deaths - Drugs Involved","volume-title":"Statistical Reports on Deaths in British Columbia - Province of British Columbia","year":"2025"},{"key":"B2","unstructured":"NSDUH State Estimates"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103237","article-title":"Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID\u221219 global pandemic: a national qualitative assessment in Canada","volume":"93","author":"Ali","year":"2021","journal-title":"Int J Drug Policy"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2021.100168","article-title":"A longitudinal study of change in substance use from before to during the COVID\u221219 pandemic in young adults","volume":"8","author":"Sylvestre","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103582","article-title":"No party, no drugs? Use of stimulants, dissociative drugs, and GHB\/GBL during the early COVID\u221219 pandemic","volume":"102","author":"Bendau","year":"2022","journal-title":"Int J Drug Policy"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19148883","article-title":"Illicit substance use and the COVID\u221219 pandemic in the United States: A scoping review and characterization of research evidence in unprecedented times","volume":"19","author":"Vo","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2023.162806","article-title":"Long\u2212term wastewater\u2212based surveillance and impacts of the COVID\u221219 pandemic on drug use trends in a U.S","volume":"877","author":"Luo","year":"2023","journal-title":"Northeast Rural Town Sci Tot Environ"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2024.135130","article-title":"Assessing daily patterns in stimulant use during the COVID\u221219 pandemic in Melbourne, Australia using wastewater analysis","volume":"476","author":"Chen","year":"2024","journal-title":"J Hazard Mater"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/add.15620","article-title":"Changes in illicit drug use and markets with the COVID\u221219 pandemic and associated restrictions: findings from the Ecstasy and Related Drugs Reporting System, 2016\u201320","volume":"117","author":"Price","year":"2022","journal-title":"Addiction"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19042230","article-title":"The impact of the COVID\u221219 pandemic on drug use behaviors, fentanyl exposure, and harm reduction service support among people who use drugs in rural settings","volume":"19","author":"Bolinski","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12954-024-00986-z","article-title":"Motivation and context of concurrent stimulant and opioid use among persons who use drugs in the rural United States: a multi\u2212site qualitative inquiry","volume":"21","author":"Fredericksen","year":"2024","journal-title":"Harm Reduct J"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109132","article-title":"Risk of cardiovascular diseases in relation to substance use disorders","volume":"229","author":"Gan","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"B13","volume-title":"Examining the societal consequences of the COVID\u221219 pandemic: Provincial Health Officer\u2019s annual report 2024","year":"2024"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1248905","article-title":"Cohort profile: the British Columbia COVID\u221219 Cohort (BCC19C)\u2014a dynamic, linked population-based cohort","volume":"12","author":"Wilton","year":"2024","journal-title":"Front Public Health"},{"key":"B15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12874-021-01235-8","article-title":"Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large\u2212scale health interventions","volume":"21","author":"Schaffer","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"B16","unstructured":"Hyndman\n              R\n            \n            \n              Athanasopoulos\n              G\n            \n            \n              Bergmeir\n              C\n            \n            \n              Caceres\n              G\n            \n            \n              Chhay\n              L\n            \n            \n              O\u2019Hara\u2212Wild\n              M\n            \n          \n          forecast: forecasting functions for time series and linear models"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v027.i03","article-title":"Automatic time series forecasting: the forecast package for R","volume":"27","author":"Hyndman","year":"2008","journal-title":"J Stat Software"},{"key":"B18","unstructured":"O\u2019Hara\u2212Wild\n              M\n            \n            \n              Hyndman\n              R\n            \n            \n              Wang\n              E\n            \n          \n          fable: forecasting models for tidy time series\n          \n          2025"},{"key":"B19","volume-title":"R: A language and environment for statistical computing","year":"2023"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-022-00630-8","article-title":"Identifying behaviours for survival and wellness among people who use methamphetamine with opioids in British Columbia: a qualitative study","volume":"19","author":"Corser","year":"2022","journal-title":"Harm Reduct J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e060447","DOI":"10.1136\/bmjopen-2021-060447","article-title":"Motivations for concurrent use of uppers and downers among people who access harm reduction services in British Columbia, Canada","volume":"12","author":"Steinberg","year":"2022","journal-title":"BMJ Open"},{"key":"B22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12954-025-01189-w","article-title":"Is fentanyl in everything? Examining the unexpected occurrence of illicit opioids in British Columbia\u2019s drug supply","volume":"22","author":"Wallace","year":"2025","journal-title":"Harm Reduct J"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjph-2023-000197","article-title":"What impact did the COVID\u221219 pandemic have on the variability of fentanyl concentrations in the Vancouver, Canada illicit drug supply","volume":"1","author":"Tobias","year":"2023","journal-title":"BMJ Public Health"},{"key":"B24","volume-title":"Illicit Drug Toxicity \u2013 Type of Drug Data to December 31, 2022","year":"2023"},{"key":"B25","volume-title":"Summary of mental health impacts of COVID\u221219: Wave 2","year":"2022"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e32316","DOI":"10.7759\/cureus.32316","article-title":"Family, individual, and other risk factors contributing to risk of substance abuse in young adults: a narrative review","volume":"14","author":"Alhammad","year":"2022","journal-title":"Cureus"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.10.010","article-title":"Conditional probabilities of substance use disorders and associated risk factors","volume":"194","author":"Marel","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"B28","volume-title":"Key substance use and mental health indicators in the United States: results from the 2017 NSDUH","year":"2018"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2050324520904540","article-title":"Percentages of problem drug use and their implications for policy making","volume":"6","author":"Schlag","year":"2020","journal-title":"Drug Sci Policy Law"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2017.1356791","article-title":"Age of initiation, psychopathology, and other substance use are associated with time to use disorder diagnosis in persons using opioids nonmedically","volume":"38","author":"Schepis","year":"2017","journal-title":"Subst Abus"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2012.12.013","article-title":"Probability and predictors of treatment\u2212seeking for prescription opioid use disorders: a national study","volume":"131","author":"Blanco","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/add.14947","article-title":"The cascade of care for opioid use disorder: a retrospective study in British Columbia, Canada","volume":"115","author":"Piske","year":"2020","journal-title":"Addiction"},{"key":"B33","volume-title":"Knowledge Update: New opioid use disorder diagnosis rates in British Columbia (2010\u20132023)","author":"Desai","year":"2024"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.230266","article-title":"Incorporating prescription psychostimulants into the continuum of care for people with stimulant use disorder in Canada","volume":"195","author":"Palis","year":"2023","journal-title":"CMAJ"},{"key":"B35","volume-title":"American Academy of Addiction Psychiatry","year":"2022"},{"key":"B36","volume-title":"Stimulant Use Disorder: Practice Update","year":"2022"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-022-01338-z","article-title":"Substance use among youth during the COVID\u221219 pandemic: a systematic review","volume":"24","author":"Layman","year":"2022","journal-title":"Curr Psychiatry Rep"},{"key":"B38","doi-asserted-by":"publisher","first-page":"44","DOI":"10.17269\/s41997-021-00567-8","article-title":"COVID\u221219 and the impacts on youth mental health: emerging evidence from longitudinal studies","volume":"113","author":"Chadi","year":"2022","journal-title":"Can J Public Health"},{"key":"B39","unstructured":"Overall trends for child and youth mental health\n          \n          2025"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-022-00435-9","article-title":"Youth substance use service providers\u2019 perspectives on use and service access in Ontario: time to reframe the discourse","volume":"17","author":"Ali","year":"2022","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"B41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12954-022-00607-7","article-title":"Harm reduction calls to action from young people who use drugs on the streets of Vancouver and Lisbon","volume":"19","author":"Can\u00eado","year":"2022","journal-title":"Harm Reduct J"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13011-022-00456-4","article-title":"A qualitative study exploring how young people perceive and experience substance use services in British Columbia, Canada","volume":"17","author":"Turuba","year":"2022","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201800427","article-title":"Barriers faced by physicians in screening for substance use disorders among adolescents","volume":"70","author":"Palmer","year":"2019","journal-title":"Psychiatr Serv"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e2420837","DOI":"10.1001\/jamanetworkopen.2024.20837","article-title":"Physician reluctance to intervene in addiction: a systematic review","volume":"7","author":"Campopiano Von Klimo","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-018-0110-8","article-title":"Barriers and facilitators affecting the implementation of substance use screening in primary care clinics","volume":"13","author":"McNeely","year":"2018","journal-title":"Addict Sci Clin Pract"},{"key":"B46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jsat.2015.09.006","article-title":"Treatment access barriers and disparities among individuals with co\u2212occurring mental health and substance use disorders","volume":"61","author":"Priester","year":"2016","journal-title":"J Subst Abuse Treat"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-023523D","article-title":"Evidence\u2212based treatment of young adults with substance use disorders","volume":"147","author":"Hadland","year":"2021","journal-title":"Pediatrics"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e0255992","DOI":"10.1371\/journal.pone.0255992","article-title":"Changes in the top 25 reasons for primary care visits during the COVID\u221219 pandemic","volume":"16","author":"Stephenson","year":"2021","journal-title":"PloS One"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e0290646","DOI":"10.1371\/journal.pone.0290646","article-title":"The impact of the early COVID-19 pandemic on healthcare system resource use and costs in two provinces in Canada: an interrupted time series analysis","volume":"18","author":"Zeitouny","year":"2023","journal-title":"PloS One"},{"key":"B50","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1186\/s12916-024-03646-y","article-title":"Chronic disease diagnoses and health service use among people who died of illicit drug toxicity in BC","volume":"22","author":"Palis","year":"2024","journal-title":"BMC Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108766","article-title":"COVID\u221219 interface with drug misuse and substance use disorders","volume":"198","author":"Cisneros","year":"2021","journal-title":"Neuropharmacology"},{"key":"B52","volume-title":"ADHD in adults","year":"2023"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/dar.13424","article-title":"Overdose deaths and the COVID\u221219 pandemic in BC, Canada","volume":"41","author":"Palis","year":"2022","journal-title":"Drug Alcohol Rev"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2025.101223","article-title":"Trends of incident adult Attention-deficit\/hyperactivity disorder diagnoses before, during and after the pandemic provincial state of emergency in British Columbia (2013-2023): a population-based study","volume":"51","author":"Hu","year":"2025","journal-title":"Lancet Reg Health Am"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1682481\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T05:41:47Z","timestamp":1778132507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1682481\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":54,"alternative-id":["10.3389\/fpsyt.2026.1682481"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1682481","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"article-number":"1682481"}}